Friday, January 09, 2009

$95 for Genentech = Too Low

The Financial Times today reported that Roche was preparing a $95 bid for Genentech (Ticker: DNA). Another low ball bid in my opinion! Genentech will not sell out for cheap. Roche has to go over $100 for me to even consider giving up my shares in Genentech. Roche likes to drag things out, but they will eventually come to their senses and pay up.


At January 10, 2009, Blogger said...

So that's why DNA keeps going higher and higher!!!


Post a Comment

<< Home